0001104659-19-074340.txt : 20191219 0001104659-19-074340.hdr.sgml : 20191219 20191219160237 ACCESSION NUMBER: 0001104659-19-074340 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191126 FILED AS OF DATE: 20191219 DATE AS OF CHANGE: 20191219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kaufman Howard CENTRAL INDEX KEY: 0001744424 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38596 FILM NUMBER: 191295794 MAIL ADDRESS: STREET 1: C/O REPLIMUNE GROUP, INC. STREET 2: 18 COMMERCE WAY CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Replimune Group, Inc. CENTRAL INDEX KEY: 0001737953 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 822082553 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: (781) 222-9600 MAIL ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 4 1 a4.xml 4 X0306 4 2019-11-26 0 0001737953 Replimune Group, Inc. REPL 0001744424 Kaufman Howard C/O REPLIMUNE GROUP, INC., 500 UNICORN PARK WOBURN MA 01801 0 1 0 0 Chief Medical Officer Common Stock 2019-11-26 4 M 0 58067 3.3 A 58067 D Employee Stock Option (right to buy) 3.3 2019-11-26 4 M 0 58067 0 D 2027-09-01 Common Stock 58067 91135 D On September 1, 2017 the Reporting Person was granted an option to purchase 149,202 shares of the Issuer's common stock, 25% of which vested on September 1, 2018 and the remainder of which vested or will vest in 36 equal monthly installments thereafter. /s/Robert Coffin, attorney-in-fact 2019-12-19